Cargando…
Heterogeneity of Cholangiocarcinoma Immune Biology
Cholangiocarcinomas (CCAs) are aggressive tumors arising along the biliary tract epithelium, whose incidence and mortality are increasing. CCAs are highly desmoplastic cancers characterized by a dense tumor microenvironment (TME), in which each single component plays a fundamental role in shaping CC...
Autores principales: | Vita, Francesca, Olaizola, Irene, Amato, Francesco, Rae, Colin, Marco, Sergi, Banales, Jesus M., Braconi, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047186/ https://www.ncbi.nlm.nih.gov/pubmed/36980187 http://dx.doi.org/10.3390/cells12060846 |
Ejemplares similares
-
Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
por: Amato, Francesco, et al.
Publicado: (2020) -
Patient-Derived Organoids as a Model for Cancer Drug Discovery
por: Rae, Colin, et al.
Publicado: (2021) -
Emerging molecular targets and therapy for cholangiocarcinoma
por: Kayhanian, Hamzeh, et al.
Publicado: (2017) -
Next-Generation Biomarkers for Cholangiocarcinoma
por: Rodrigues, Pedro M., et al.
Publicado: (2021) -
PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
por: Olaizola, Paula, et al.
Publicado: (2023)